Cargando…
Inflammatory Leptomeningeal Cytokines Mediate COVID-19 Neurologic Symptoms in Cancer Patients
SARS-CoV-2 infection induces a wide spectrum of neurologic dysfunction that emerges weeks after the acute respiratory infection. To better understand this pathology, we prospectively analyzed of a cohort of cancer patients with neurologic manifestations of COVID-19, including a targeted proteomics a...
Autores principales: | Remsik, Jan, Wilcox, Jessica A., Babady, N. Esther, McMillen, Tracy A., Vachha, Behroze A., Halpern, Neil A., Dhawan, Vikram, Rosenblum, Marc, Iacobuzio-Donahue, Christine A., Avila, Edward K., Santomasso, Bianca, Boire, Adrienne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833316/ https://www.ncbi.nlm.nih.gov/pubmed/33508216 http://dx.doi.org/10.1016/j.ccell.2021.01.007 |
Ejemplares similares
-
Leveraging Molecular and Immune-Based Therapies in Leptomeningeal Metastases
por: Wilcox, Jessica A., et al.
Publicado: (2022) -
Leptomeningeal Metastases: New Opportunities in the Modern Era
por: Wilcox, Jessica A., et al.
Publicado: (2022) -
ETMM-03. CANCER CELLS DEPLOY LIPOCALIN- 2 TO COLLECT LIMITING IRON IN LEPTOMENINGEAL METASTASIS
por: Chi, Yudan, et al.
Publicado: (2021) -
Leptomeningeal metastatic cells adopt two phenotypic states
por: Remsik, Jan, et al.
Publicado: (2020) -
BSLD-05 ESTABLISHMENT AND CHARACTERIZATION OF MOUSE MODELS OF LEPTOMENINGEAL METASTASIS
por: Derderian, Camille, et al.
Publicado: (2023)